Clinical Trials in Los Angeles

Showing 1921-1940 of 8,055 trials

STEM-PD Open Label Extension (OLE)

NCT04799418

This study seeks to establish the safety and efficacy of extended twice daily time-varying caloric vestibular stimulation treatments for treating symptoms associated with Parkinson's disease. Only participants who completed the STEM-PD randomized controlled trial portion (NCT04797611) are eligible to participate in the open label extension portion.

Parkinson DiseaseParkinson's Disease and Parkinsonism

Scion NeuroStim148 participantsStarted Sep 2022

Scottsdale, Arizona, United States • Los Angeles, California, United States • Boca Raton, Florida, United States +12 more locations

COMPLETEDPhase 3< 1 mile

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

NCT03025308

The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the parent studies of filgotinib in rheumatoid arthritis (RA).

Rheumatoid Arthritis

Alfasigma S.p.A.2,731 participantsStarted Feb 2017

Huntsville, Alabama, United States • Gilbert, Arizona, United States • Phoenix, Arizona, United States +342 more locations

STEM-PD Open Label Extension (OLE)

Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

Find Trials by Condition in Los Angeles

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Vaginal Ecosystem and Network in the United States Study

Trigeminal Nerve Stimulation for Children With Prenatal Alcohol Exposure

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

TTX-030 Single Agent and in Combination With Immunotherapy or Chemotherapy for Patients With Advanced Cancers

Feasibility Study to Evaluate Therapeutic Ultrasound (TUS) to Acutely Increase the Perfusion in Peripheral Arterial Disease (PAD)

A Study to Evaluate ASP0367 in Participants With Primary Mitochondrial Myopathy

24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Cough Reduction in IPF With Nalbuphine ER